Equillium (EQ) director Barbara Troupin receives grant of 70,000 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Equillium, Inc. director Barbara Troupin received a grant of options to purchase 70,000 shares of common stock at an exercise price of $2.84 per share. These director stock options vest in twelve equal monthly installments starting on May 28, 2026 and will be fully vested no later than the issuer's next annual stockholder meeting following the grant date. After this grant, Troupin holds 70,000 derivative securities directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Troupin Barbara
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Option (right to buy) | 70,000 | $0.00 | -- |
Holdings After Transaction:
Director Stock Option (right to buy) — 70,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 70,000 options
Exercise price: $2.84 per share
Expiration date: May 27, 2036
+1 more
4 metrics
Option grant size
70,000 options
Director stock option grant to Barbara Troupin
Exercise price
$2.84 per share
Exercise price for director stock options
Expiration date
May 27, 2036
Option expiration for 70,000-share grant
Post-grant derivative holdings
70,000 derivative securities
Total options held following the reported transaction
Key Terms
Director Stock Option, grant/award acquisition, vests in twelve equal monthly installments, exercise price, +1 more
5 terms
Director Stock Option financial
"Director Stock Option (right to buy)"
grant/award acquisition financial
"transaction_action: grant/award acquisition"
vests in twelve equal monthly installments financial
"The option vests in twelve equal monthly installments"
exercise price financial
"conversion_or_exercise_price: 2.8400"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-05-27"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What did Equillium (EQ) director Barbara Troupin report in this Form 4?
Barbara Troupin reported receiving a grant of options for 70,000 Equillium common shares. The options are a compensation-related award, not an open-market purchase, and give her the right to buy stock at a fixed exercise price of $2.84 per share.
What are the key terms of Barbara Troupin’s Equillium (EQ) stock option grant?
The grant covers 70,000 director stock options with an exercise price of $2.84 per share. The options relate to Equillium common stock and expire on May 27, 2036, providing long-term potential equity exposure if the options become fully vested and are exercised.
How do Barbara Troupin’s Equillium (EQ) options vest according to the Form 4?
The options vest in twelve equal monthly installments starting on May 28, 2026. Regardless of the monthly schedule, the award will be fully vested on the date of Equillium’s annual meeting of stockholders that follows the grant date, if that occurs earlier.
How many Equillium (EQ) derivative securities does Barbara Troupin hold after this transaction?
After this transaction, she holds 70,000 derivative securities related to Equillium common stock. These represent the full amount of the reported option grant and are held directly, subject to the vesting schedule and the stated expiration date in 2036.